-
Exploring the etiology of colitis: insights from gut microbiota research Gut Microbes (IF 12.2) Pub Date : 2025-06-03
Guanru Qian, Xiaolin Chen, Gang Liu, Jiankang Yu, Sijia Zhong, Jiaxi Yang, Yefei Sun, Jianping Zhou -
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma Gut Microbes (IF 12.2) Pub Date : 2025-05-30
George B. H. Green, Alexis N. Cox-Holmes, Gillian H. Marlow, Anna Claire E. Potier, Yong Wang, Lianna Zhou, Dongquan Chen, Casey D. Morrow, Braden C. McFarland -
Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiology Gut Microbes (IF 12.2) Pub Date : 2025-05-27
Frederick Clasen, Suleyman Yildirim, Muzaffer Arıkan, Fernando Garcia-Guevara, Lűtfű Hanoğlu, Nesrin H. Yılmaz, Aysu Şen, Handan Kaya Celik, Alagoz Aybala Neslihan, Tuǧçe Kahraman Demir, Zeynep Temel, Adil Mardinoglu, David L. Moyes, Mathias Uhlen, Saeed Shoaie -
New insights in amino sugar metabolism by the gut microbiome Gut Microbes (IF 12.2) Pub Date : 2025-05-26
Wenqiang Shen, Jan Freark de Boer, Folkert Kuipers, Jingyuan FuGut microorganisms inhabiting the intestinal tract play key roles in host's health and disease. A properly functioning gut microbiome requires the availability of adequate carbon, nitrogen and energy sources. One of the main sources of energy for intestinal bacteria are glycans, of which amino sugars are important components. Amino sugars are a class of carbohydrates in which one or more hydroxyl groups
-
Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease Gut Microbes (IF 12.2) Pub Date : 2025-05-25
Da-Ya Zhang, Da Li, Shi-Ju Chen, Li-Jun Zhang, Xu-Li Zhu, Fa-Di Chen, Chen Chen, Qi Wang, Yiping Du, Jian-Xin Xiong, Shi-Mei Huang, Xiao-Dong Zhang, Yan-Ting Lv, Fan Zeng, Run-Xiang Chen, Xianfeng Huang, Fengjiao Mao, Shuo Zhou, Qicen Yao, Yuliang Huang, Runyu Chen, Ying Mo, Yunqian Xie, Yue-Hong Jiang, Zhai Chen, Cui-Yi Mo, Jia-Jia Chen, Fei-Hu BaiGut microbiota exerts a pivotal influence on the development of Metabolic Associated Fatty Liver Disease (MAFLD), although the specific contributions of individual bacterial strains and their metabolites remain poorly defined. We conducted stool shotgun metagenomic sequencing and plasma untargeted metabolomics in a large prospective cohort comprising 120 MAFLD patients and 120 matched healthy controls
-
Fecal microbiota transplantation from a healthy pouch donor for chronic pouchitis: a proof-of-concept study Gut Microbes (IF 12.2) Pub Date : 2025-05-25
Sabrina Just Kousgaard, Sebastian Mølvang Dall, Mads Albertsen, Hans Linde Nielsen, Ole Thorlacius-UssingChronic pouchitis is a common complication after ileal pouch-anal anastomosis (IPAA) with limited treatment options. In this case series, we aimed to investigate clinical and microbiome changes, as well as adverse events, associated with using fecal microbiota transplantation (FMT) from a donor with a normal functioning IPAA to induce remission in patients with chronic pouchitis. Methods The study
-
Adaptations in gut Bacteroidales facilitate stable co-existence with their lytic bacteriophages Gut Microbes (IF 12.2) Pub Date : 2025-05-23
Adrián Cortés-Martín, Colin Buttimer, Jessie L. Maier, Ciara A. Tobin, Lorraine A. Draper, R. Paul Ross, Manuel Kleiner, Colin Hill, Andrey N. Shkoporov -
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection Gut Microbes (IF 12.2) Pub Date : 2025-05-23
Marybeth Creskey, Fabiola Silva Angulo, Qing Wu, Levi Tamming, Emily E. F. Fekete, Kai Cheng, Zhibin Ning, Angela Wang, Patrícia Brito Rodrigues, Vinícius de Rezende Rodovalho, Marco Aurélio Ramirez Vinolo, Daniel Figeys, Xuguang Li, Francois Trottein, Xu Zhang -
Indole-3-lactic acid suppresses colorectal cancer via metabolic reprogramming Gut Microbes (IF 12.2) Pub Date : 2025-05-23
Shizhen Zhou, Kai Wang, Jiandong Huang, Zhen Xu, Qinggang Yuan, Lixiang Liu, Zhifeng Wang, Ji Miao, Hao Wang, Tingting Wang, Wenxian Guan, Chao DingResearch indicates that abnormal gut microbiota metabolism is linked to colorectal cancer (CRC) progression, but the role of microbiota-related tryptophan metabolism disruption remains unclear. Using metagenomic sequencing and targeted Trp metabolomics, our research identified that CRC patients had abnormal indole-3-lactic acid (ILA) levels, which were related to tumor malignancy. Exogenous ILA administration
-
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism Gut Microbes (IF 12.2) Pub Date : 2025-05-22
Daan Bunt, Markus Schwalbe, Fittree Hayeeawaema, Sahar El AidyMangiferin (MAN), a natural C-glycosylxanthone, is recognized for its health-promoting effects in traditional medicinal preparations. However, its poor bioavailability and limited intestinal permeability restrict its direct biological activity in vivo. Previous studies have suggested a potential bacterial breakdown of MAN into norathyriol (NOR), an aglycone with significantly higher bioavailability
-
The influence of early life exposures on the infant gut virome Gut Microbes (IF 12.2) Pub Date : 2025-05-21
Yichang Zhang, Josué L. Castro-Mejía, Ling Deng, Shiraz A. Shah, Jonathan Thorsen, Cristina Leal Rodríguez, Leon E. Jessen, Moïra B. Dion, Bo Chawes, Klaus Bønnelykke, Søren J. Sørensen, Hans Bisgaard, Sylvain Moineau, Marie-Agnès Petit, Jakob Stokholm, Dennis S. Nielsen -
ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions Gut Microbes (IF 12.2) Pub Date : 2025-05-21
Eduard Flores Ventura, Jonathan A. Lane, Sondra Turjeman, Nikoletta Vidra, Gisela Adrienne Weiss, Gabriele Gross, Ching-Yu Chang, Omry KorenPregnancy induces notable alterations in the gut, vaginal, and oral microbiota driven by hormonal, immune, metabolic, dietary, and environmental factors. During pregnancy, the gut microbiota is characterized by increased proportions of the genus Bifidobacterium and the phyla Pseudomonadota (formerly Proteobacteria) and Actinomycetota (formerly Actinobacteria). These changes occur alongside reduced
-
Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH Gut Microbes (IF 12.2) Pub Date : 2025-05-21
Thomas Zöggeler, Anna Maria Kavallar, Adam Robert Pollio, Denise Aldrian, Cornelia Decristoforo, Sabine Scholl-Bürgi, Thomas Müller, Georg Friedrich VogelAlterations in the gut microbiome affect the development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) or metabolic dysfunction-associated steatohepatitis (MASH). We analyzed microbiomes of obese children with and without MASLD, MASH, and healthy controls. Electronic databases were searched for studies on the gut microbiome in children with obesity with/without MASLD
-
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease Gut Microbes (IF 12.2) Pub Date : 2025-05-21
Huaying Wu, Jingjing Chen, Shuyuan Guo, Jinhao Deng, Zimeng Zhou, Xuan Zhang, TianTian Qi, Fei Yu, Qi YangMetabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) is increasing in prevalence worldwide and has become the greatest potential risk for cirrhosis and hepatocellular liver cancer. Currently, the role of gut microbiota in the development of MASLD has become a research hotspot. The development of MASLD can affect the homeostasis of gut microbiota, and significant changes in the composition
-
Akkermansia muciniphila reverses neuronal atrophy in Negr1 knockout mice with depression-like phenotypes Gut Microbes (IF 12.2) Pub Date : 2025-05-19
Hee-Gon Hwang, Ji-Woo Park, Hyo-Jin Lee, Moon Yi Ko, Minhan Ka, Yun Kyung Lee, Jaeyoon Choi, Su-A In, Ye-Eun Lee, Soojin Lee, Min-Soo Kim, Jeong-Yoon KimGenetic predispositions can shape the gut microbiome, which in turn modulates host gene expression and impacts host physiology. The complex interplay between host genetics and the gut microbiome likely contributes to the development of neuropsychiatric disorders, yet the mechanisms behind these interactions remain largely unexplored. In this study, we investigated the gut microbiota in Negr1 knockout
-
CD44 is a macrophage receptor for TcdB from Clostridioides difficile that via its lysine-158 succinylation contributes to inflammation Gut Microbes (IF 12.2) Pub Date : 2025-05-19
Zhuo Chen, Wenzi Zhang, Danni Wang, Ruiqin Luo, Yuexin Yao, Xiaoyang Tao, Lu Li, Qin Pan, Xiaoming SunToxin B (TcdB) is a critical virulence factor in Clostridioides difficile-associated disease (CDAD), which activates macrophages to promote inflammation and epithelial damage. However, the mechanism by which TcdB targets inflammation-related receptors on the macrophage surface and the underlying molecular mechanisms remain unknown. The frizzled-binding domain of TcdB (TcdB-FBD) is a promising target
-
The intestinal mucosa-associated microbiota in IBD-associated arthritis displays lower relative abundance of Roseburia intestinalis Gut Microbes (IF 12.2) Pub Date : 2025-05-18
Madeline Alizadeh, Uni Wong, Bernadette C. Siaton, Michael T. France, Seema A. Patil, Lauren George, Dania Hudhud, Kiran Motwani, William H. Scott, Jean-Pierre Raufman, Erik C. von Rosenvinge, Raymond K. Cross, Jacques RavelThe most common extra-intestinal manifestation (EIM) of inflammatory bowel disease (IBD), IBD-associated arthritis (IAA), occurs in 25-40% of patients and can be debilitating. In IBD, mucosal and stool microbiota richness is decreased, and compositional changes can precede or accompany disease onset. Likewise, spondyloarthritides are associated with altered gut microbiota, with overlapping bacterial
-
Interventions targeting the gut microbiota and their possible effect on gastrointestinal and neurobehavioral symptoms in autism spectrum disorder Gut Microbes (IF 12.2) Pub Date : 2025-05-16
Evelyn Takyi, Khemlal Nirmalkar, James Adams, Rosa Krajmalnik-BrownAutism spectrum disorder (ASD) is a developmental disorder that is characterized by deficits in social communication and restricted, repetitive, and stereotyped behaviors. In addition to neurobehavioral symptoms, children with ASD often have gastrointestinal symptoms (e.g. constipation, diarrhea, gas, abdominal pain, reflux). Several studies have proposed the role of gut microbiota and metabolic disorders
-
Intestinal and esophageal microbiota in esophageal cancer development and treatment Gut Microbes (IF 12.2) Pub Date : 2025-05-16
Yuta Baba, Kohei Tajima, Kiyoshi YoshimuraEsophageal cancer (EC) is the eleventh most commonly diagnosed cancer, and its prognosis remains poor. Several challenges remain for improving the clinical outcomes of EC, and improving technologies for early detection, diversifying treatment options, and advancing personalized treatment are essential. Alterations in the intestinal and esophageal microbiota are associated with the pathogenesis and
-
Virome drift in ulcerative colitis patients: faecal microbiota transplantation results in minimal phage engraftment dominated by microviruses Gut Microbes (IF 12.2) Pub Date : 2025-05-15
Daan Jansen, Sara Deleu, Clara Caenepeel, Tine Marcelis, Ceren Simsek, Gwen Falony, Kathleen Machiels, João Sabino, Jeroen Raes, Séverine Vermeire, Jelle MatthijnssensUlcerative colitis (UC) is an inflammatory bowel disease characterized by recurrent colonic inflammation. Standard treatments focus on controlling inflammation but remain ineffective for one-third of patients. This underscores the need for alternative approaches, such as fecal microbiota transplantation (FMT), which transfers healthy donor microbiota to patients. The role of viruses in this process
-
Anaerobutyricum soehngenii improves glycemic control and other markers of cardio-metabolic health in adults at risk of type 2 diabetes Gut Microbes (IF 12.2) Pub Date : 2025-05-15
Ilias Attaye, Julia K. Bird, Max Nieuwdorp, Sahin Gül, Jos F. M. L. Seegers, Steven Morrison, Stijn Hofkens, Hilde Herrema, Nam Bui, Marie-Luise Puhlmann, Willem M. de VosAnaerobutyricum soehngenii (previously Eubacterium hallii) is a butyrate-producing next-generation beneficial microbe generally recognized as safe. Several short-term intervention trials by A. soehngenii L2-7 have shown improvement of insulin sensitivity in prediabetic subjects and type 2 diabetes patients. To determine the long-term cardiometabolic benefits and safety, we performed a 3-month double-blind
-
Deep learning-based detection of bacterial swarm motion using a single image Gut Microbes (IF 12.2) Pub Date : 2025-05-14
Yuzhu Li, Hao Li, Weijie Chen, Keelan O’Riordan, Neha Mani, Yuxuan Qi, Tairan Liu, Sridhar Mani, Aydogan Ozcan -
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI diarrhea Gut Microbes (IF 12.2) Pub Date : 2025-05-14
Lamei Wang, Xinhua Chen, Nira R. Pollock, Javier A. Villafuerte Gálvez, Carolyn D. Alonso, Dangdang Wang, Kaitlyn Daugherty, Hua Xu, Junhu Yao, Yulin Chen, Ciaran P. Kelly, Yangchun CaoClostridioides difficile infection (CDI) has been recognized as a leading cause of healthcare-associated infections and a considerable threat to public health globally. Increasing evidence suggests that the gut microbiota plays a key role in the pathogenesis of CDI. The taxonomic composition and functional capacity of the gut microbiota associated with CDI have not been studied systematically. Here
-
Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation Gut Microbes (IF 12.2) Pub Date : 2025-05-14
Yun Zhang, Ying Wei, Xuejie Han, Ling Shi, Hui Yu, Xuanrui Ji, Yunlong Gao, Qianhui Gao, Linwei Zhang, Yu Duan, Wenpeng Li, Yue Yuan, Jing Shi, Liang Cheng, Yue LiAging is a primary driver of the escalating prevalence of heart failure (HF). Age-associated gut microbiota dysbiosis has been implicated in various age-related diseases, yet its role in age-related HF remains largely unexplored. In this study, we sought to explore the potential link between age-related gut microbiota alterations and HF in the elderly. We analyzed a publicly available single-cell sequencing
-
Microbial metabolites as engines of behavioral variation across animals Gut Microbes (IF 12.2) Pub Date : 2025-05-13
Eric Siaw Ntiri, Adam Chun Nin WongThe microbiome, especially that present in the gut, has emerged as a key modulator of animal behavior. However, the extent of its influence across species and behavioral repertoires, as well as the underlying mechanisms, remains poorly understood. Increasing evidence suggests that microbial metabolites play an important role in driving behavioral variation. In this review, we synthesize findings from
-
The gut–brain axis in Alzheimer’s disease is shaped by commensal gut microbiota derived extracellular vesicles Gut Microbes (IF 12.2) Pub Date : 2025-05-13
Junhua Xie, Lien Van Hoecke, Elien Van Wonterghem, Griet Van Imschoot, Vanessa Andries, Lars Vereecke, Roosmarijn E. VandenbrouckeEmerging clinical and experimental evidence highlight the involvement of gut microbiota in the onset and progression of neurodegenerative diseases such as Alzheimer's disease (AD) via neuroinflammatory processes along the gut-brain axis. Despite this, the precise mechanisms governing gut microbial involvement in AD remain elusive. In this study, we observed that AppNL-G-F AD mice raised under germ-free
-
Bacteriophage-driven DNA inversions shape bacterial functionality and long-term co-existence in Bacteroides fragilis Gut Microbes (IF 12.2) Pub Date : 2025-05-12
Shaqed Carasso, Roni Keshet-David, Jia Zhang, Haitham Hajjo, Dana Kadosh-Kariti, Tal Gefen, Naama Geva-Zatorsky -
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization Gut Microbes (IF 12.2) Pub Date : 2025-05-11
Shuaiming Jiang, Shi Huang, Zeng Zhang, Wenyao Ma, Zhe Han, Yuan Song, Dongxue Huo, Weipeng Cui, Jiachao ZhangProbiotics encounter colonization resistance from native gut microbiomes, affecting their effectiveness. Genetic engineering of probiotics lacks universal applicability, as gut microbiotas are highly individualized. Here, we employed probiotic Lactiplantibacillus plantarum HNU082 (Lp082) to test whether Lp082 gut-adapted mutants can resolve colonization resistance in a new gut environment. Relying
-
Microbial-derived peptidases are altered in celiac disease, non-celiac gluten sensitivity, and functional dyspepsia: a systematic review and re-analysis of the duodenal microbiome Gut Microbes (IF 12.2) Pub Date : 2025-05-10
Jennifer C. Pryor, Cheenie Nieva, Nicholas J. Talley, Guy D. Eslick, Kerith Duncanson, Grace L. Burns, Emily C. Hoedt, Simon KeelyDietary gluten triggers symptoms in patients with gluten-related disorders (GRDs) including celiac disease (CeD), non-celiac gluten sensitivity (NCGS), and subsets of patients with functional dyspepsia (FD). The gastrointestinal microbiota is altered in these patients when compared to healthy individuals. As the microbiota is crucial for the hydrolysis of gluten, we hypothesized that the capacity of
-
Engineered bacteria as an orally administered anti-viral treatment and immunization system Gut Microbes (IF 12.2) Pub Date : 2025-05-09
Nitin S. Kamble, Shindu Thomas, Tushar Madaan, Nadia Ehsani, Saqib Sange, Kiersten Tucker, Alexis Muhumure, Sarah Kunkler, Nalinikanth KotagiriThe emergence of new viral pathogens necessitates innovative antiviral therapies and vaccines. Traditional approaches, such as monoclonal antibodies and vaccines, are often hindered by resistance, limited effectiveness, and high costs. Here, we develop an engineered probiotic-based antiviral platform using Escherichia coli Nissle 1917 (EcN), capable of providing both mucosal and systemic immunity via
-
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome Gut Microbes (IF 12.2) Pub Date : 2025-05-09
Anna Samarra, Simone Renwick, Aleksandr A. Arzamasov, Dmitry A. Rodionov, Kennedy Spann, Raul Cabrera-Rubio, Antia Acuna-Gonzalez, Cecilia Martínez-Costa, Lindsay Hall, Nicola Segata, Andrei L. Osterman, Lars Bode, MCarmen ColladoBreast milk, rich in human milk oligosaccharides (HMOs), supports the early-life colonization of beneficial bacteria such as bifidobacteria and lactobacilli, potentially reducing early-life antibiotic resistance. However, antibiotic treatment may interfere with the beneficial functions of HMO-degrading bacteria. This study investigated the metabolism of HMOs by bifidobacteria and lactobacilli isolated
-
Fusobacterium mortiferum and its metabolite 5-aminovaleric acid promote the development of colorectal cancer in obese individuals through Wnt/β-catenin pathway by DKK2 Gut Microbes (IF 12.2) Pub Date : 2025-05-09
Jiaxin Deng, Jiawei Zhang, Mingli Su, Juan Li, Yuping Su, Qinghua Zhong, Jiancong Hu, Yongcheng Chen, Sen Liao, Dezheng Lin, Xuefeng GuoColorectal cancer (CRC) is one of the most prevalent cancers worldwide, with high incidence and mortality rates. An increasing body of research suggests that obesity is a significant risk factor for the development of CRC. Moreover, recent findings have highlighted the close association between the gut microbiota and both obesity and CRC. Despite this, the specific mechanisms by which the gut microbiota
-
Distinct gut microbiota and metabolome features of tissue-specific insulin resistance in overweight and obesity Gut Microbes (IF 12.2) Pub Date : 2025-05-08
Kelly M. Jardon, Alexander Umanets, Anouk Gijbels, Inez Trouwborst, Gabby B. Hul, Els Siebelink, Lars M.M. Vliex, Jacco J.A.J. Bastings, Rosa Argamasilla, Elodie Chenal, Koen Venema, Lydia A. Afman, Gijs H. Goossens, Ellen E. BlaakInsulin resistance (IR) is an early marker of cardiometabolic deterioration which may develop heterogeneously in key metabolic organs, including the liver (LIR) and skeletal muscle (MIR). This tissue-specific IR is characterized by distinct metabolic signatures, but the role of the gut microbiota in its etiology remains unclear. Here, we profiled the gut microbiota, its metabolites and the plasma metabolome
-
Novel cross-feeding human gut microbes metabolizing tryptophan to indole-3-propionate Gut Microbes (IF 12.2) Pub Date : 2025-05-08
Janina N. Zünd, Denisa Mujezinovic, Markus Reichlin, Serafina Plüss, Marina Caflisch, Serina Robinson, Christophe Lacroix, Benoit PuginTryptophan-derived indoles produced by the gut microbiota, particularly indole-3-propionate (IPA), are key compounds associated with gastrointestinal balance and overall health. Reduced levels of IPA have been associated with inflammatory bowel disease, type 2 diabetes, and colorectal cancer. Since fiber-rich diets have been shown to promote IPA, we aimed to decipher fiber-specific effects and identify
-
Indole signaling in Escherichia coli : a target for antivirulence therapy? Gut Microbes (IF 12.2) Pub Date : 2025-05-07
Sofia Razzaq Meo, Tom Van de Wiele, Tom DefoirdtPathogenic Escherichia coli are a major cause of infections in both humans and animals, leading to conditions such as severe diarrheal diseases, urinary tract infections, enteritis, and septicemia. To combat bacterial infections, antibiotics are widely utilized. However, the extensive and inappropriate use of antibiotics has fueled the development and spread of antibiotic resistance, posing a significant
-
Defining enteric bacterial pathogenesis using organoids: Citrobacter rodentium uses EspC, an atypical mucinolytic protease, to penetrate mouse colonic mucus Gut Microbes (IF 12.2) Pub Date : 2025-05-05
Yan Chen, Ashley Gilliland, Qiaochu Liang, Xiao Han, Hyungjun Yang, Jocelyn Chan, Dominique Lévesque, Kyung-Mee Moon, Parandis Daneshgar, François-Michel Boisvert, Leonard Foster, Wesley F. Zandberg, Kirk Bergstrom, Hong B. Yu, Bruce A. VallanceEnteric bacterial pathogens pose significant threats to human health; however, the mechanisms by which they infect the mammalian gut in the face of daunting host defenses remain to be fully defined. For the attaching and effacing (A/E) bacterial family member and murine pathogen Citrobacter rodentium, its virulence strategy appears to involve penetration of the colonic mucus barrier to reach the underlying
-
Fecal microbiota transplantation: a tale of two regulatory pathways Gut Microbes (IF 12.2) Pub Date : 2025-04-30
Diane E. Hoffmann, Gail H. Javitt, Colleen R. Kelly, Josbert J. Keller, Simon Mark Dahl Baunwall, Christian Lodberg HvasFecal microbiota transplantation (FMT) is a procedure involving the transfer of intestinal microbiota from a healthy donor to a patient to restore a functional intestinal microbiome. First described in modern science in 1958, the use of FMT has been practiced for decades, but only during the past dozen years have clinical frameworks and legal regulations from competent authorities been developed. Future
-
Multi-species probiotic supplement enhances vagal nerve function – results of a randomized controlled trial in patients with depression and healthy controls Gut Microbes (IF 12.2) Pub Date : 2025-04-29
Sabrina Mörkl, Martin Narrath, Daria Schlotmann, Marie-Therese Sallmutter, Julia Putz, Julia Lang, Andreas Brandstätter, Rene Pilz, Helmut Karl Lackner, Nandu Goswami, Bianca Steuber, Jasmin Tatzer, Sonja Lackner, Sandra Holasek, Annamaria Painold, Emanuel Jauk, Julian Wenninger, Angela Horvath, Nicolai Spicher, Asmus Barth, Mary I Butler, Jolana Wagner-SkacelMajor depression (MD) significantly impacts individual well-being and society. The vagus nerve plays a pivotal role in the gut-brain axis, facilitating bidirectional communication between these systems. Recent meta-analyses suggest potential antidepressant effects of probiotics, although their mechanisms remain unclear. This study aimed to assess the impact of a multi-species probiotic (OMNi-BiOTiC®
-
Mechanosensory Piezo2 regulated by gut microbiota participates in the development of visceral hypersensitivity and intestinal dysmotility Gut Microbes (IF 12.2) Pub Date : 2025-04-29
Haonan Zheng, Yuzhu Chen, Siqi Lu, Zuojing Liu, Yinchao Ma, Cunzheng Zhang, Yiming Zhang, Jindong Zhang, Chang Liu, Ming Chu, Fei Pei, Shuangjiang Liu, Liping DuanThe gut microbiota plays a crucial role in the manifestation of intestinal dysfunction associated with irritable bowel syndrome (IBS). The mechanosensory Piezo2 has been implicated in the regulation of intestinal function. However, it remains unclear whether Piezo2 is modulated by the gut microbiota, thus contributing to the development of visceral hypersensitivity and gut dysmotility. The study enrolled
-
Role of insulinemic and inflammatory dietary patterns on gut microbial composition and circulating biomarkers of metabolic health among older American men Gut Microbes (IF 12.2) Pub Date : 2025-04-29
Sushma Nepal, Ni Shi, Rebecca Hoyd, Daniel J. Spakowicz, Eric Orwoll, James M. Shikany, Nicola Napoli, Fred K. TabungChronic low-grade inflammation and hyperinsulinemia are linked with metabolic dysfunction and dysbiosis. This study investigated the role of dietary inflammatory and insulinemic potential on gut microbiome and circulating health biomarkers in older men. Data from the Osteoporotic Fractures in Men (MrOS) study were analyzed. Reversed Empirical Dietary Inflammatory Pattern (rEDIP), Empirical Dietary
-
High-resolution analysis of the treated coeliac disease microbiome reveals strain-level variation Gut Microbes (IF 12.2) Pub Date : 2025-04-28
Jelle Slager, Hanna L. Simpson, Ranko Gacesa, Lianmin Chen, Ineke L. Tan, Jody Gelderloos, Astrid Maatman, Cisca Wijmenga, Alexandra Zhernakova, Jingyuan Fu, Rinse K. Weersma, Gieneke Gonera, Iris H. Jonkers, Sebo Withoff -
Gut microbes–spinal connection is required for itch sensation Gut Microbes (IF 12.2) Pub Date : 2025-04-28
Tong Jin, Si-Yuan Li, Hong-Li Zheng, Xiao-Dan Liu, Yue Huang, Gan Ma, Ya-Xuan Zhao, Xiao-Tian Zhao, Li Yang, Qi-Hui Wang, Hong-Jun Wang, Chengyong Gu, Zhiqiang Pan, Fuqing LinThe gut microbiota has been linked to a number of neurological disorders. However, it is unclear whether the gut microbiota is involved in the genesis of chronic itch, a refractory condition that afflicts patients both physically and mentally. Here, we report that depletion of gut microbiota enhances tolerance to itch in mice orally administered with antibiotics (ABX) and mice free of germ. Of note
-
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis Gut Microbes (IF 12.2) Pub Date : 2025-04-25
Leena Sapra, Chaman Saini, Pradyumna K. Mishra, Bhavuk Garg, Sarika Gupta, Vikrant Manhas, Rupesh K. SrivastavaOsteoporosis is a systemic skeletal disease that leads to lower bone mineral density and intensifies the risk of unexpected fractures. Recently, our group reported that numerical defect in the frequencies of Bregs along with their compromised tendency to produce IL-10 cytokine further aggravates inflammatory bone loss in post-menopausal osteoporosis (PMO). Dysbiosis induced mucosal injury and leaky
-
Gut microbiota regulates hepatic ketogenesis and lipid accumulation in ketogenic diet-induced hyperketonemia by disrupting bile acid metabolism Gut Microbes (IF 12.2) Pub Date : 2025-04-24
Zhengzhong Luo, Yixin Huang, Kang Yong, Dan Wu, Linfeng Zheng, Xueping Yao, Liuhong Shen, Shumin Yu, Baoning Wang, Suizhong CaoThe ketogenic diet (KD) induces prolonged hyperketonemia, characterized by elevated circulating level of β-hydroxybutyrate. However, the KD can negatively affect host metabolic health by altering the gut microbial community. Despite this, the regulatory effect of the gut microbiota on hepatic ketogenesis and triacylglycerol (TAG) accumulation during a KD remains poorly understood. Here, we hypothesized
-
Helminth reshapes host gut microbiota and immunoregulation by deploying an antimicrobial program of innate immunity Gut Microbes (IF 12.2) Pub Date : 2025-04-23
Yang Zou, Lixia Pu, Aijiang Guo, Yaqi Li, Yihui Liu, Yugui Wang, Yingying Ding, Xiaowei Du, Xiaola Guo, Shaohua Zhang, Xuepeng Cai, Shuai WangHelminths can manipulate their host's gut microbiota, with the expansion of the lactobacilli population being a common feature. This process profoundly influences host immunoregulation, yet the underlying mechanisms remain almost unknown. Using a tissue-dwelling helminth model (larval Echinococcus multilocularis) while validating key findings from other helminth infections, we show that helminths harness
-
Gut microbiota and associated metabolites: key players in high-fat diet-induced chronic diseases Gut Microbes (IF 12.2) Pub Date : 2025-04-22
Wei Du, Zhen-Ping Zou, Bang-Ce Ye, Ying ZhouExcessive intake of dietary fats is strongly associated with an increased risk of various chronic diseases, such as obesity, diabetes, hepatic metabolic disorders, cardiovascular disease, chronic intestinal inflammation, and certain cancers. A significant portion of the adverse effects of high-fat diet on disease risk is mediated through modifications in the gut microbiota. Specifically, high-fat diets
-
Genetic diversity of Salmonella enterica during acute human infections Gut Microbes (IF 12.2) Pub Date : 2025-04-22
Alexandra Grote, Natav Hendin, Sharon Amit, Boaz Adani, Galia Rahav, Amos Adler, Jonathan Livny, Ohad Gal-Mor, Ashlee M. EarlThe ubiquitous bacterial pathogen Salmonella enterica is the causative agent of both enteric fever and gastroenteritis. Despite its significant global health burden, we lack an understanding of its genetic diversity during acute infection, with ramifications for treatment and prevention. Here, we investigated within-host infection diversity of acute salmonellosis using whole-genome sequencing of blood
-
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation Gut Microbes (IF 12.2) Pub Date : 2025-04-21
Laura Buttler, David A. Velázquez-Ramírez, Anja Tiede, Anna M. Conradi, Sabrina Woltemate, Robert Geffers, Birgit Bremer, Vera Spielmann, Julia Kahlhöfer, Anke R.M Kraft, Dirk Schlüter, Heiner Wedemeyer, Markus Cornberg, Christine Falk, Marius Vital, Benjamin MaasoumyDecompensated liver cirrhosis (dLC) is associated with intestinal dysbiosis, however, underlying reasons and clinical consequences remain largely unexplored. We investigated bacterial and fungal microbiota, their relation with gut barrier integrity, inflammation, and cirrhosis-specific complications in dLC-patients. Competing-risk analyses were performed to investigate clinical outcomes within 90 days
-
Role of gut microbiome in suppression of cancers Gut Microbes (IF 12.2) Pub Date : 2025-04-21
Yao Xu, Zhaoyu Gao, Jiaying Liu, Qianqian Yang, Shunjiang XuThe pathogenesis of cancer is closely related to the disruption of homeostasis in the human body. The gut microbiome plays crucial roles in maintaining the homeostasis of its host throughout lifespan. In recent years, a large number of studies have shown that dysbiosis of the gut microbiome is involved in the entire process of cancer initiation, development, and prognosis by influencing the host immune
-
Delivery mode, birth order, and sex impact neonatal microbial colonization Gut Microbes (IF 12.2) Pub Date : 2025-04-19
Katherine M. Kennedy, Andreas Plagemann, Julia Sommer, Marie Hofmann, Wolfgang Henrich, Michael G. Surette, Thorsten Braun, Deborah M. SlobodaThe initial microbial colonization of the infant gut during birth plays a critical role in shaping both immediate and long-term health outcomes. While mode of delivery is a known determinant of this colonization process, the potential impacts of infant sex and birth order remain underexplored. This study investigates the influence of delivery mode, infant sex, and birth order (maternal parity) on the
-
E. coli genetically modified for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult Gut Microbes (IF 12.2) Pub Date : 2025-04-18
J. Scott Lee, Daniel J. Kao, Corey S. Worledge, Zachary F. Villamaria, Ruth X. Wang, Nichole M. Welch, Rachael E. Kostelecky, Sean P. ColganThe gut microbiota transforms energy stored as undigestible carbohydrates into a remarkable number of metabolites that fuel intestinal bacterial communities and the host tissue. Colonic epithelial cells at the microbiota-host interface depend upon such microbiota-derived metabolites (MDMs) to satisfy their energy requisite. Microbial dysbiosis eliciting MDM loss contributes to barrier dysfunction and
-
Exclusive breastfeeding is associated with the gut microbiome maturation in infants according to delivery mode Gut Microbes (IF 12.2) Pub Date : 2025-04-16
Nathalia F. Naspolini, Paulo A. Schüroff, Pedro A. R. Vanzele, Davi Pereira-Santos, Tamires Amabili Valim, Kevin S. Bonham, André Fujita, Maria Rita Passos-Bueno, Patricia C. B. Beltrão-Braga, André C. P. L. F. Carvalho, Vanja Klepac-Ceraj, Guilherme V. Polanczyk, Alline C. Campos, Carla R. TaddeiExclusive breastfeeding (EBF) plays a crucial role in infant gut microbiome assembly and development. However, few studies have investigated the effects of EBF in restoring a perturbed microbiome. In this study, we applied whole metagenomic sequencing to assess the gut microbiome assembly in 525 Brazilian infants from 3 to 9 months of age of the Germina Cohort, demonstrating the early determinants
-
Urease in acetogenic Lachnospiraceae drives urea carbon salvage in SCFA pools Gut Microbes (IF 12.2) Pub Date : 2025-04-15
Isaac J. Firth, Marissa A.R. Sim, Bradley G. Fitzgerald, Ailish E. Moore, Christian R. Pittao, Connor Gianetto-Hill, Samantha Hess, Autumn R. Sweeney, Emma Allen-Vercoe, Matthew T. SorbaraThe gut microbiota produces short-chain fatty acids (SCFA) and acidifies the proximal colon which inhibits enteric pathogens. However, for many microbiota constituents, how they themselves resist these stresses is unknown. The anaerobic Lachnospiraceae family, which includes the acetogenic genus Blautia, produce SCFA, are genomically diverse, and vary in their capacity to acidify culture media. Here
-
Metagenomic source tracking after microbiota transplant therapy Gut Microbes (IF 12.2) Pub Date : 2025-04-15
Susan L. Hoops, Daphne Moutsoglou, Byron P. Vaughn, Alexander Khoruts, Dan KnightsReliable engraftment assessment of donor microbial communities and individual strains is an essential component of characterizing the pharmacokinetics of microbiota transplant therapies (MTTs). Recent methods for measuring donor engraftment use whole-genome sequencing and reference databases or metagenome-assembled genomes (MAGs) to track individual bacterial strains but lack the ability to disambiguate
-
Genetic variation in gut microbe as a key regulator of host social behavior in C. elegans Gut Microbes (IF 12.2) Pub Date : 2025-04-14
Ying Li, Ruijie Bai, Yao Zhu, Peng Shi, Tao Wang, Dianshuang Zhou, Jianteng Zhou, Tao Zhu, Xinrong Zhang, Rongrong Gu, Xiaoyue Ding, Hao Chen, Xiangming Wang, Zuobin ZhuGut microbiota have been shown to influence the social behaviors of their hosts, while variations in host genetics can affect the composition of the microbiome. Nonetheless, the degree to which genetic variations in microbial populations impact host behavior, as well as any potential transgenerational effects, remains inadequately understood. Utilizing C. elegans as a model organism, we identified
-
Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate Gut Microbes (IF 12.2) Pub Date : 2025-04-14
Jing-Juan Hu, Fan Deng, Qi-Shun Sun, Qing-Ming Xiong, Yue Min, Si-Yuan Feng, Ze-Bin Lin, Peng-Han Chen, Zhen Hu, Ling Wu, Xiao-Feng Chen, Sun Xie, Wei-Feng Liu, Cai Li, Ke-Xuan LiuLiver injury is an independent risk factor for multiple organ dysfunction and high mortality in patients with sepsis. However, the pathological mechanisms and therapeutic strategies for sepsis-associated liver injury have not been fully elucidated. Time-restricted feeding (TRF) is a promising dietary regime, but its role in septic liver injury remains unknown. Using 16S rRNA gene sequencing, Q200 targeted
-
Effects of bacteriophages on gut microbiome functionality Gut Microbes (IF 12.2) Pub Date : 2025-04-14
Elena Kurilovich, Naama Geva-ZatorskyThe gut microbiome, composed of bacteria, fungi, and viruses, plays a crucial role in maintaining the delicate balance of human health. Emerging evidence suggests that microbiome disruptions can have far-reaching implications, ranging from the development of inflammatory diseases and cancer to metabolic disorders. Bacteriophages, or "phages", are viruses that specifically infect bacterial cells, and
-
Bacterial extracellular vesicles in osteoarthritis: a new bridge of the gut-joint axis Gut Microbes (IF 12.2) Pub Date : 2025-04-11
Luyu Niu, Wanzhuo Chen, Zhifeng Yin, Hongbo Tan, Jin Cui, Jiacan SuOsteoarthritis (OA) is a degenerative joint disease primarily characterized by cartilage degeneration. Increasing evidence suggests that there is an interplay between the gut microbiota (GM) and joint health, known as the gut-joint axis. In recent years, with the advancement of bacterial extracellular vesicles (BEVs) research, its role in the gut-joint axis has attracted increasing attention. BEVs
-
Gut microbiota and epigenetic inheritance: implications for the development of IBD Gut Microbes (IF 12.2) Pub Date : 2025-04-11
Xue Guo, Jianhong Li, Jing Xu, Leiting Zhang, Chen Huang, Yuqiang Nie, Youlian ZhouInflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is considered significant global health concerns worldwide. Many studies have demonstrated that environmental and dietary factors influence the gut microbiota, which in turn orchestrates the host immune responses. These interactions are also involved in complex metabolic processes that contribute to the pathogenesis
-
Fusobacterium nucleatum exacerbates colitis via STAT3 activation induced by Acetyl-CoA accumulation Gut Microbes (IF 12.2) Pub Date : 2025-04-11
Zixuan Xiang, Xiangyun Li, Xiaoli Wang, Beiying Deng, Haodong He, Miao Xu, Xiaohan Wu, Cheng Tan, Yafei Liu, Baoping Yu, Jixiang Zhang, Weiguo DongFusobacterium nucleatum (F. nucleatum) has emerged as a potential contributor to ulcerative colitis (UC) pathogenesis, although the specific mechanisms remain incompletely understood. This study demonstrates that F. nucleatum promotes colitis by disrupting intestinal barrier integrity, inducing apoptosis in epithelial cells, and modulating inflammatory pathways. Furthermore, we demonstrate that F.